Drug intelligence / Profile preview

tinidazole

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Tinidazole is a synthetic antiprotozoal and antibacterial agent belonging to the nitroimidazole class. It is used primarily to treat protozoan infections such as trichomoniasis (a sexually transmitted infection), giardiasis (intestinal infection), and amebiasis (intestinal and extra-intestinal). It is also indicated for bacterial vaginosis in adult women. The drug acts as a prodrug; its nitro group is reduced by microbial electron transport proteins (such as ferredoxin) within susceptible organisms. This reduction generates free nitro radicals that bind covalently to DNA and other macromolecules in the pathogen—causing DNA damage and cell death. Tinidazole was developed in 1972 and remains widely used globally for anaerobic amoebic and bacterial infections[1][2][3][4][5].

Brand names
TindamaxFasigynZilTinizolCiprored -TDatisole SRArzanTinvistaCostiniTinifas FCTinibid DSTinica -500
Other names
tinidazole
02

Targets

Neuraminidase

Beyond the preview

Go deeper on tinidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tinidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call